Zynerba Pharmaceuticals (NASDAQ: ZYNE) Looks Ready to Surge Higher
Our target potential upside is 35% to 135% in the next 3-5 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 11, 2021
Our target potential upside is 35% to 135% in the next 3-5 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 10, 2021
Our target potential upside is 18% to 75% in the next 4-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 9, 2021
Our target potential upside is 43% to 79% in the next 4-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 8, 2021
Our target potential upside is 8% to 23% in the next 3-5 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 4, 2021
Our target potential upside is nearly 10% to 20% in the next 3-6 months.
Read More